Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 30;40(6):1203-1212.
doi: 10.1093/ndt/gfae268.

Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease

Young Su Joo  1   2   3 , Hae-Ryoung Yun  1   2   3 , Hyung Woo Kim  1   3 , Hee Byung Koh  1   4 , Chan-Young Jung  1   5 , Tae-Ik Chang  6 , Jung Tak Park  1   3 , Sue Kyung Park  7 , Young Youl Hyun  8 , Yeong Hoon Kim  9 , Suah Sung  10 , Tae-Hyun Yoo  1 , Kook-Hwan Oh  11 , Shin-Wook Kang  1 , Seung Hyeok Han  1
Affiliations

Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease

Young Su Joo et al. Nephrol Dial Transplant. .

Abstract

Background: Smoking cessation is recommended to reduce excess atherosclerotic cardiovascular disease (ASCVD) and mortality in patients with chronic kidney disease (CKD). However, this recommendation is largely based on observational studies on the general population Therefore, we aimed to evaluate the association of smoking dose and smoking cessation duration with ASCVD and mortality in patients with CKD.

Methods: We compiled a comprehensive pooled dataset comprising 66 245 participants with CKD from the KNOW-CKD and the UK Biobank cohort. Additionally, we included 307 353 participants without CKD from the UK Biobank cohort. Participants were categorized according to smoking dose and duration of smoking cessation base on a questionnaire. The primary outcome was a composite of ASCVD events or all-cause mortality.

Results: Over a median follow-up period of 13.2 years, 14 671 (22.1%) participants reached the primary outcome. In the pooled CKD cohort, compared to never smokers, and former and current smokers exhibited a 1.30- and 2.14-fold higher risk of the primary outcome, respectively. Among former smokers, the hazard ratios (HRs) (95% confidence intervals [CIs]) for smoking loads <20 and ≥20 pack-years were 1.05 (1.00-1.10) and 2.14 (2.05-2.25), respectively. The increased risk of the primary outcome was attenuated by longer smoking cessation. The HRs (95% CIs) for smoking cessation of <10 years, 10-20 years, and ≥20 years were 1.75 (1.65-1.86), 1.43 (1.34-1.52), and 1.11 (1.06-1.16), respectively, compared with never smokers. This association was also observed in individuals without CKD, but the risk was comparable between former smokers with smoking cessation ≥20 years and non-smokers, suggesting that a longer cessation is required in patients with CKD to offset the smoking-related adverse effects.

Conclusions: Among former smokers with CKD, the risk of ASCVD or mortality was substantially attenuated with less smoking load and a longer duration of smoking cessation.

Keywords: atherosclerotic cardiovascular disease; chronic kidney disease; smoking cessation.

PubMed Disclaimer